BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36166871)

  • 21. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.
    Bang JS; Choi NY; Lee M; Ko K; Lee HJ; Park YS; Jeong D; Chung HM; Ko K
    Anim Cells Syst (Seoul); 2018; 22(2):132-139. PubMed ID: 30460090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of four postmortem dura-derived iPS cell lines from four control individuals with genotypic and brain-region-specific transcriptomic data available through the BrainSEQ consortium.
    Sawada T; Benjamin KJM; Brandtjen AC; Tietze E; Allen SJ; Paquola ACM; Kleinman JE; Hyde TM; Erwin JA
    Stem Cell Res; 2020 Jul; 46():101806. PubMed ID: 32446240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a human iPSC line XMDYYYi001-A from a patient with Becker muscular dystrophy harboring duplications of exons 2-19 in dystrophin gene.
    Wang D; Lin J; Jin M; Wang N
    Stem Cell Res; 2021 May; 53():102298. PubMed ID: 33799273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
    Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
    Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
    Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
    Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
    Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and characterization of two iPSC lines from human adipose tissue-derived stem cells of healthy donors.
    Zhou XB; Li H; Li F; Song XK; Liu T; Ma T; Guo HY; Wu N; Li J
    Stem Cell Res; 2020 Oct; 48():101973. PubMed ID: 32896746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
    Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
    Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation.
    Murakami N; Ishikawa T; Kondo T; Imamura K; Tsukita K; Enami T; Funayama M; Shibukawa R; Matsumoto S; Izumi Y; Ohta E; Obata F; Kaji R; Inoue H
    Stem Cell Res; 2017 Oct; 24():36-39. PubMed ID: 29034893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation.
    Janz A; Chen R; Regensburger M; Ueda Y; Rost S; Klopocki E; Günther K; Edenhofer F; Duff HJ; Ergün S; Gerull B
    Stem Cell Res; 2020 Jul; 46():101856. PubMed ID: 32521499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin.
    Yan X; Xu N; Meng C; Wang B; Yuan J; Wang C; Li Y
    Am J Transl Res; 2016; 8(2):419-32. PubMed ID: 27158336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of human induced pluripotent stem cell line MUi028-A from normal fetal skin fibroblasts.
    Chumchuen S; Satirapod C; Tangprasittipap A; Hongeng S
    Stem Cell Res; 2022 Apr; 60():102675. PubMed ID: 35114587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of human iPSC line from patient of Indian ethnicity carrying homozygous CD8/9 (+G) beta thalassemia mutation.
    Tembe S; Fernandes S; Khan N; Melinkeri S; Kale V; Limaye L
    Stem Cell Res; 2020 Apr; 44():101772. PubMed ID: 32278313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
    Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
    Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation.
    Yang CS; Lopez CG; Rana TM
    Stem Cells; 2011 Oct; 29(10):1528-36. PubMed ID: 21898684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.
    Maali A; Maroufi F; Sadeghi F; Atashi A; Kouchaki R; Moghadami M; Azad M
    Epigenomics; 2021 Apr; 13(8):631-647. PubMed ID: 33823614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
    Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
    Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.